NCT03317574View on ClinicalTrials.gov

MEDITOXIN® in Treatment of Crow's Feet Line

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

August 17, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

May 14, 2018

Conditions
Crow's Feet Lines
Interventions
DRUG

botulinum toxin type A

24 units botulinum toxin Type A (total dose) injected into bilateral Crow's Feet Line areas

DRUG

botulinum toxin type A

24 units botulinum toxin Type A (total dose) injected into bilateral Crow's Feet Line areas

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Gyeonggi-do

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03317574 - MEDITOXIN® in Treatment of Crow's Feet Line | Biotech Hunter | Biotech Hunter